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ABSTRACT: Aldehydes are easily transformed into vicinal
diamines and piperazines through a one-pot procedure
including a Darzens reaction and treatment with an amine
or diamine and then with a reducing agent. Additionally,
quinoxalines can be accessed by reaction with 1,2-benzenedi-
amine under oxidative conditions. These transformations are
simple methods for the preparation of synthetically interesting
monosubstituted diamines, piperazines, and quinoxalines.
■ INTRODUCTION
Vicinal diamines are important building blocks found in many
bioactive molecules (Figure 1),1 natural products,2 and metal
complexes displaying interesting properties.3 Also, quinoxalines
and piperazines have interesting medical properties. For
instance, quinoxaline derivatives display anticancer,4 antiviral,5
antibacterial,6 anti-inflammatory,7 and antibiotic8 activities. A
piperazine moiety is considered a “privileged scaffold” in
medicinal chemistry9 and is present in many biologically active
molecules.
Monosubstituted vicinal diamines are present in potent
bioactive compounds such as tetracyclic antidepressants1
mianserin and mirtazapine or k-opioid antagonist ICI-
1994411e (Figure 1A). Although interesting approaches have
been recently reported for the preparation of monosubsti-
tuted10 and disubstituted11 diamines, more approaches are
welcome.
We report herein the preparation of monosubstituted
diamines from aldehydes in a one-pot three-step process.
The process comprises first the formation of an epoxysulfone
by a Darzens reaction between an aldehyde and chlorome-
thylphenylsulfone and then addition of an amine attacking the
β position of the epoxide, affording an α-aminoaldehyde, which
upon reductive amination with a second amine gives the
corresponding diamine (Figure 1B). This chemical trans-
formation is inspired by our previous work about chemical
transformations of nitroepoxides.11
■ RESULTS AND DISCUSSION
We first prepared epoxysulfone 1a through a Darzens reaction
between benzaldehyde and chloromethylphenylsulfone. Then,
epoxysulfone 1a was combined with benzylamine in dichloro-
methane (DCM) for 8 h at room temperature, and then
sodium borohydride was added. The reaction worked
satisfactorily, affording diamine 2a (Scheme 1). However, the
conversion of epoxysulfone 1a into diamine 2a was very low
yielding.
Hence, we turned our attention to a one-pot procedure for
the transformation of aldehydes into diamines by combining
the four reactions shown in Scheme 1. One-pot procedures
represent interesting synthetic approaches,12 which might
improve yields as compared to step-wise sequences. First,
benzaldehyde was reacted with chloromethylphenylsulfone
previously treated with sodium tert-butoxide in dichloro-
methane. After the mixture was stirred for 1 h at 0 °C and then
for 1 h at room temperature, benzylamine (3 equiv.) was
added, and the resulting mixture was stirred for 8 h at room
temperature and then sodium borohydride (6 equiv.) was
added and stirred again for 8 h. Under these experimental
conditions, diamines were obtained but chemical yields were
not satisfying (Table 1, entries 4, 7, and 9). Under these
conditions, the corresponding benzyl p-methylbenzyl amine
was also isolated when using p-tolualdehyde, denoting an
undesired attack of the benzylamine on the epoxysulfone
(Scheme 2).
To increase the yield, an optimization process was
performed by modifying the temperature, solvent, and number
of equivalents. Higher yields were obtained when a temper-
ature of 0 °C was kept during the amine treatment, favoring
the attack of the amine at the β-position. This slowed the
reaction, and the duration for that step had to be increased up
to 18 h. Optimized conditions also comprise an increase of the
number of equivalents of amine and sodium borohydride (4
and 8, respectively). A screening of solvents gave 1,2-
dichloroethane as the best option in all cases (entries 1, 5, 8,
and 13). Probably, the improvement of the yield with 1,2-
dichloroethane as compared to dichloromethane is due to its
lower volatility avoiding losses of solvents after such a long
reaction time. Other assayed conditions such as the use of
lithium chloride as an additive and tetrahydrofuran (THF) as a
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solvent (entry 9), phase-transfer conditions (entry 10), or the
use of sodium triacetoxyborohydride instead of sodium
borohydride (entry 11) did not improve the yield.
Aliphatic aldehydes (propionaldehyde and isobutyralde-
hyde) and ortho-substituted aromatic aldehydes (2-chloro-
benzaldehyde) were also assayed under different conditions,
but only traces of desired diamines were detected. Then, we
assayed the use of two different amines during the process
instead of only one. Thus, N-benzylmethylamine (4 equiv.)
was added first, then benzylamine (4 equiv.) was added when
TLC showed total consumption of epoxysulfone and finally
sodium borohydride. Following this procedure, diamines 2e−h
were prepared (Scheme 3). However, when benzaldehyde was
first treated with benzylamine and N-benzylmethylamine was
then added, diamine 2a was obtained. Presumably, the
aminoaldehyde intermediate resulting from the opening of
epoxysulfone by benzylamine (see Figure 1b) reacts with a
second equivalent of benzylamine to give a corresponding
imine in contrast with N-benzylmethylamine. The same
experimental procedure was also used for diamines 2e−h,
using morpholine instead of N-benzylmethylamine, and only
traces of desired diamines were detected.
Then, we extended the study to the use of other amines
different from benzylamines. When optimized experimental
conditions (Table 1) were applied but n-butylamine was used
as a starting material instead of benzylamine, the chemical yield
of desired diamines was very low, even when the reaction was
performed at room temperature or at reflux. To activate
epoxysulfone for the amine attack, Lewis acids were added to
the reaction mixture after epoxysulfone formation. Magnesium
bromide, magnesium sulfate, and titanium isopropoxide had no
Figure 1. (a) Examples of diamines. (b) Reaction design.
Scheme 1. Synthesis of Diamines through Epoxysulfones
Table 1. Synthesis of Diamines from Aldehydesa
entry R1 diamine solvent yield (%)b
1 Ph 2a DCE 44
2 pMe-Ph 2b DCM 15
3 pMe-Ph 2b THF 34
4 pMe-Ph 2b DCE 24c
5 pMe-Ph 2b DCE 40
6 pCl-Ph 2c DCM 25
7 pCl-Ph 2c DCE 22c
8 pCl-Ph 2c DCE 52
9 pCl-Ph 2c THF 4d
10 pCl-Ph 2c DCE 23e
11 pCl-Ph 2c DCE 5f
12 pF-Ph 2d DCE 26c
13 pF-Ph 2d DCE 30
aReactions were performed using benzylamine (4 equiv.) and sodium
borohydride (8 equiv.) at 0 °C. bYield of the isolated product.
cReactions were carried out at room temperature. dThe reaction was
carried out by adding lithium chloride (10 equiv.). eThe reaction was
carried out under phase-transfer conditions with aq. NaOH (50%) (1
mL/mmol) and tetra-n-butyl ammonium bromide (0.2 equiv.).
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effect on the reactivity of epoxysulfones. However, the addition
of lithium chloride (10 equiv.) afforded the desired diamines
2i−j (Scheme 4). Tetrahydrofuran gave higher yields than
dichloroethane probably because of the higher solubility of
lithium chloride.
Cyclic diamines were also prepared. Piperazines 3a and 3b
were prepared following the same experimental conditions as
those for diamines starting from benzaldehyde and tolualde-
hyde, respectively (Scheme 5). Quinoxaline 4 was prepared
using 1,2-benzenediamine and in the presence of air13
(Scheme 5).
■ CONCLUSIONS
In summary, we reported herein that 1,2-diamines, piperazines,
and quinoxalines can be prepared starting from aldehydes. It is
a one-pot procedure through three steps: A Darzens reaction
with chloromethylsulfone and sodium tert-butoxide, treatment
with an excess of amines or diamines, and reductive treatment
to afford corresponding diamines. Also, quinoxalines can be
prepared in a similar manner but using 1,2-benzenediamine
upon oxidative conditions. Further research related to the
synthetic use of epoxysulfones is going on in our lab and will
be reported in the near future.
■ EXPERIMENTAL SECTION
General Information. All reactions were carried out under
a nitrogen atmosphere with magnetic stirring, unless otherwise
specified. Used reagents and solvents were obtained from
commercial sources and were purified accordingly before use.
EM Science Silica Gel 60 was used for column chromatog-
raphy, whereas TLC was performed with precoated plates
(Kieselgel 60, F254, 0.25 mm).
1H NMR spectra and 13C NMR
spectra were recorded in CDCl3 (
1H, 7.24 ppm; 13C 77.0 ppm)
solution at 30 °C on a 300 MHz or a 400 MHz NMR
spectrometer. Mass spectra were recorded on a QTOF I
(quadrupole−hexapole−TOF) mass spectrometer with an
orthogonal Z-spray-electrospray interface.
General Experimental Procedure for the Synthesis of
Epoxysulfone 1a. t-BuONa (1.1 mmol, 1.1 equiv.) was
slowly added to a cold (0 °C) stirred solution of chloromethyl
phenyl sulfone (1.1 mmol, 1.1 equiv.) in THF (5 mL). The
mixture was stirred for 15 min, followed by dropwise addition
of a solution of the corresponding aldehyde (1 mmol, 1 equiv.)
Scheme 2. Formation of Secondary Amines
Scheme 3. Synthesis of Differently Substituted Diamines
from Aldehydes
Scheme 4. Synthesis of Diamines from Aliphatic Amines
Scheme 5. Synthesis of Cyclic Diamines
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in THF (5 mL). The reaction mixture was then stirred for 30
min and monitored by TLC. Quenching was done by adding
ammonium chloride saturated aqueous solution (10 mL), and
then the mixture was allowed to warm to room temperature
before being extracted with ethyl ether (3 × 10 mL). The
organic layers were washed with 1 M hydrochloric acid (10
mL), then with sodium bicarbonate saturated aqueous solution
(10 mL), and finally with brine; then, the layers were dried
using Na2SO4 and concentrated under vacuum. The crude
material was purified using chromatography (silica gel,
hexanes/ethyl acetate (9:1 to 7:3)) to give the pure
compound.
2-Phenyl-3-(phenylsulfonyl)oxirane (1a). White crystals,
mp 105−106 °C (yield 231 mg, 89%): 1H NMR (400 MHz,
CDCl3) δ 7.96−7.89 (m, 2H), 7.70−7.63 (m, 1H), 7.61−7.51
(m, 2H), 7.33−7.26 (m, 3H), 7.22−7.19 (m, 2H), 4.52 (d, J =
1.5 Hz, 1H), 4.11 (d, J = 1.6 Hz, 1H) ppm; 13C NMR (101
MHz, CDCl3) δ 136.94, 134.58, 132.72, 129.60, 129.50,
128.88, 128.82, 126.10, 71.05, 57.48 ppm; HRMS (ESI) m/z
calcd for C14H12O3S [M + H]
+: 261.0585, found: 261.0582; IR
(KBr) ν 3313, 3060, 3025, 2920, 2830, 1757, 1676, 1513,
1495, 1454, 1119, 818, 740, 700 cm−1.
General Experimental Procedure for the Synthesis of
Diamines. To an ice-cold, stirred solution of the correspond-
ing epoxysulfone (1 mmol, 1 equiv.) in DCM (10 mL), the
corresponding amine (3 mmol, 3 equiv.) was slowly added.
The reaction mixture was stirred for 8 h, and then NaBH4 (6
mmol, 6 equiv.) was added portionwise. The reaction mixture
was then stirred for 1.5 h and was monitored by TLC. Then, it
was quenched by ammonium chloride saturated aqueous
solution (10 mL) and was allowed to warm to room
temperature before being extracted with DCM (3 × 10 mL).
The organic layers resulting from the extraction were washed
with 1 M hydrochloric acid (10 mL), then with sodium
bicarbonate saturated aqueous solution (10 mL), and finally
with brine; then, these layers were dried using Na2SO4 and
concentrated under vacuum. The resulting crude material was
purified by chromatography (silica gel, hexanes/ethyl acetate
(7:3 to 1:1)) to give the desired pure compound.
Method A. t-BuONa (1.2 mmol, 1.2 equiv.) was added to a
0 °C cold solution of chloromethyl phenyl sulfone (1.2 mmol,
1.2 equiv.) in DCE (5 mL). The resulting mixture was stirred
for 15 min, and then the corresponding aldehyde (1 mmol, 1
equiv.) dissolved in DCE (5 mL) was added dropwise. The
mixture was stirred for 1 h in a cold ice-bath and then for 1 h at
room temperature until complete formation of epoxysulfone as
monitored by TLC. Then, the reaction mixture was cooled at 0
°C and the amine (4 mmol, 4 equiv.) was slowly added. The
reaction mixture was kept for 18 h at −8 °C, and then NaBH4
(8 mmol, 8 equiv.) was slowly added. The resulting mixture
was stirred for 8 h. Then, it was quenched with saturated
ammonium chloride aqueous solution (10 mL) and was
allowed to warm up to room temperature and extracted with
DCM (3 × 10 mL). The organic layers were washed with 1 M
hydrochloric acid (10 mL), saturated sodium bicarbonate
aqueous solution (10 mL), and brine; dried using Na2SO4; and
concentrated under vacuum. The crude mixture was purified
by chromatography (silica gel, hexanes/ethyl acetate (7:3 to
1:1)) to afford the pure compound.
N1,N2-Dibenzyl-1-phenylethane-1,2-diamine (2a). Yellow-
ish oil (yield 139 mg, 44%): 1H NMR (300 MHz, CDCl3) δ
7.26−7.07 (m, 15H), 3.71−3.56 (m, 4H), 3.40 (d, J = 13.2 Hz,
1H), 2.72−2.65 (m, 2H), 2.21 (br s, 2H) ppm; 13C NMR (75
MHz, CDCl3) δ 142.50, 140.70, 140.27, 128.66, 128.50,
128.46, 128.34, 128.22, 127.48, 127.43, 127.07, 126.96, 61.72,
56.07, 53.73, 51.42 ppm; HRMS (ESI) m/z calcd for
C22H24N2 [M + H]
+: 317.2018, found: 317.2015; IR (KBr)
ν 3421, 3281, 3062, 3029, 2957, 2921, 2864, 1630, 1497, 1462,
1445, 1370, 1316, 1291, 1239, 1170, 1131, 1111, 1080, 1048,
1031, 1005, 952, 919, 901, 862, 817, 762, 745, 695 cm−1.
N1,N2-Dibenzyl-1-(p-tolyl)ethane-1,2-diamine (2b). Yel-
lowish oil (yield 132 mg, 40%): 1H NMR (300 MHz,
CDCl3) δ 7.23−7.12 (m, 12H), 7.10−7.05 (m, 2H), 3.69−
3.61 (m, 3H), 3.62 (d, J = 13.4 Hz, 1H), 3.42 (d, J = 13.2 Hz,
1H), 2.73−2.64 (m, 2H), 2.26 (s, 3H), 2.16 (br s, 2H) ppm;
13C NMR (75 MHz, CDCl3) δ 140.67, 140.23, 139.32, 136.96,
129.31, 128.43, 128.39, 128.29, 128.17, 128.14, 127.32, 127.00,
126.88, 61.33, 56.06, 53.70, 51.31, 21.18 ppm; HRMS (ESI)
m/z calcd for C23H26N2 [M + H]
+: 331.2174, found:
331.2169; IR (KBr) ν 3329, 3062, 3027, 2922, 2834, 1604,
1509, 1455, 1350, 1223, 1158, 1122, 1054, 837, 742, 700 cm−1.
N1,N2-Dibenzyl-1-(4-chlorophenyl)ethane-1,2-diamine
(2c). Yellowish oil (yield 182 mg, 52%): 1H NMR (400 MHz,
CDCl3) δ 7.30−7.14 (m, 14H), 3.70−3.63 (m, 3H), 3.61 (d, J
= 13.6 Hz, 1H), 3.41 (d, J = 13.3 Hz, 1H), 2.75−2.60 (m, 2H),
1.70 (br s, 2H) ppm; 13C NMR (101 MHz, CDCl3) δ 141.05,
140.42, 140.19, 128.86, 128.49, 128.41, 128.39, 128.16, 128.04,
127.16, 127.00, 126.91, 66.74, 63.11, 61.11, 55.99, 53.70,
51.32, 51.16 ppm; HRMS (ESI) m/z calcd for C22H23ClN2 [M
+ H]+: 351.1628, found: 351.1634; IR (KBr) ν 3310, 3061,
3026, 2920, 2831, 1755, 1603, 1494, 1454, 1361, 1204, 1126,
1073, 1029, 746, 701 cm−1.
N1,N2-Dibenzyl-1-(4-fluorophenyl)ethane-1,2-diamine
(2d). Yellowish oil (yield 100 mg, 30%): 1H NMR (400 MHz,
CDCl3) δ 7.28−7.12 (m, 12H), 7.02−6.92 (m, 2H), 3.69−
3.63 (m, 3H), 3.61 (d, J = 12.7 Hz, 1H), 3.41 (d, J = 13.3 Hz,
1H), 2.75−2.61 (m, 2H), 1.77 (br s, 2H) ppm; 13C NMR (101
MHz, CDCl3) δ 162.06 (d, J = 244.9 Hz), 140.52, 140.30,
138.17 (d, J = 3.0 Hz), 128.84 (d, J = 7.8 Hz), 128.48, 128.40,
128.37, 128.16, 128.04, 126.97, 126.89, 115.30 (d, J = 21.1
Hz), 61.06, 56.16, 53.72, 51.31 ppm; HRMS (ESI) m/z calcd
for C22H23FN2 [M + H]
+, found 335.1913: 335.1912; IR
(KBr) ν 3428, 3062, 3027, 2923, 2848, 1649, 1612, 1493,
1455, 1421, 1351, 1092, 1037, 1015, 828, 743, 701 cm−1.
N1,N2-Dibenzyl-N1-methyl-1-phenylethane-1,2-diamine
(2e). Yellowish oil (yield 135 mg, 41%): 1H NMR (300 MHz,
CDCl3) δ 7.46−7.20 (m, 15H), 3.98−3.84 (m, 3H), 3.58 (d, J
= 13.3 Hz, 1H), 3.38−3.23 (m, 2H), 3.20 (br s, 1H), 2.92 (dd,
J = 11.9, 5.7 Hz, 1H), 2.11 (s, 3H) ppm; 13C NMR (75 MHz,
CDCl3) δ 139.58, 137.29, 128.91, 128.81, 128.50, 128.47,
128.32, 128.27, 128.21, 127.60, 127.14, 126.96, 66.63, 58.59,
53.59, 49.77, 37.48 ppm; HRMS (ESI) m/z calcd for
C23H26N2 [M + H]
+: 331.2174, found: 331.2167; IR (KBr)
ν 3416, 3060, 3026, 2931, 2858, 1656, 1603, 1496, 1455, 1385,
751, 702 cm−1.
N1,N2-Dibenzyl-N1-methyl-1-(p-tolyl)ethane-1,2-diamine
(2f). Yellowish oil (yield 127 mg, 37%): 1H NMR (300 MHz,
CDCl3) δ 7.27−7.13 (m, 12H), 7.10−6.99 (m, 2H), 3.83−
3.76 (m, 2H), 3.73 (d, J = 13.3 Hz, 1H), 3.51 (br s, 1H), 3.44
(d, J = 13.3 Hz, 1H), 3.24−3.08 (m, 2H), 2.78 (dd, J = 11.9,
5.7 Hz, 1H), 2.27 (s, 3H), 1.97 (s, 3H) ppm; 13C NMR (75
MHz, CDCl3) δ 139.61, 139.40, 137.25, 133.94, 128.92,
128.84, 128.52, 128.44, 128.33, 127.19, 126.96, 66.13, 58.56,
53.51, 49.71, 37.42, 21.17 ppm; HRMS (ESI) m/z calcd for
C24H28N2 [M + H]
+: 345.2331, found: 345.2328; IR (KBr) ν
13C NMR (400 MHz) δ 3433, 3062, 3028, 2923, 2849, 2796,
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1672, 1645, 1604, 1510, 1454, 1368, 1226, 1160, 1016, 837,
740, 701 cm−1.
N1,N2-Dibenzyl-1-(4-chlorophenyl)-N1-methylethane-1,2-
diamine (2g). Yellowish oil (yield 145 mg, 40%): 1H NMR
(400 MHz, CDCl3) δ 7.35−7.14 (m, 12H), 7.12−7.04 (m,
2H), 3.86−3.75 (m, 3H), 3.42 (d, J = 13.3 Hz, 1H), 3.22 (d, J
= 13.3 Hz, 1H), 3.18 (s, 1H), 3.14 (dd, J = 12.0, 8.9 Hz, 1H),
2.80 (dd, J = 12.0, 5.7 Hz, 1H), 1.97 (s, 3H) ppm; HRMS
(ESI) m/z calcd for C23H25ClN2 [M + H]
+: 365.1788, found:
365.1788.; 13C NMR (101 MHz, CDCl3) δ 139.10, 135.51,
133.47, 130.11, 128.77, 128.63, 128.60, 128.56, 128.42, 128.39,
128.38, 127.43, 127.11, 65.63, 58.59, 53.29, 49.27, 37.34 ppm;
IR (KBr) ν 3345, 3061, 3027, 2926, 2846, 2795, 1674, 1638,
1603, 1495, 1454, 1368, 1124, 1077, 1025, 745, 702 cm−1.
N1,N2-Dibenzyl-1-(4-fluorophenyl)-N1-methylethane-1,2-
diamine (2h). Yellowish oil (yield 125 mg, 36%): 1H NMR
(300 MHz, CDCl3) δ 7.27−7.08 (m, 12H), 7.01−6.90 (m,
2H), 3.83−3.69 (m, 3H), 3.42 (d, J = 13.3 Hz, 1H), 3.34 (br s,
1H), 3.24−3.07 (m, 2H), 2.77 (dd, J = 11.9, 5.8 Hz, 1H), 1.96
(s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 162.23 (d, J =
245.8 Hz), 139.32, 139.29, 133.05 (d, J = 3.3 Hz), 130.31 (d, J
= 7.9 Hz), 128.77, 128.54, 128.38, 128.29, 127.25, 127.06,
115.07 (d, J = 21.0 Hz), 65.80, 58.57, 53.51, 49.75, 37.38 ppm;
HRMS (ESI) m/z calcd for C23H25FN2 [M + H]
+: 349.2080,
found: 349.2078; IR (KBr) ν 3367, 3062, 3027, 2924, 2850,
2796, 1659, 1596, 1494, 1455, 1396, 1093, 1016, 828, 741, 701
cm−1.
Method B. t-BuONa (1.2 mmol, 1.2 equiv.) was added to
an ice-cold solution of chloromethyl phenyl sulfone (1.2 mmol,
1.2 equiv.) in THF (5 mL). The mixture was stirred for 15
min; then, the corresponding aldehyde (1 mmol, 1 equiv.) was
slowly added as a solution in THF (5 mL). The reaction
mixture was then stirred for 1 h at 0 °C and for 1 h at room
temperature. When TLC showed complete formation of
epoxysulfone, the reaction was cooled at −8 °C and the
corresponding amine (4 mmol, 4 equiv.) was added followed
by addition of LiCl (10 mmol, 10 equiv.). The reaction
mixture was kept for 18 h at −8 °C. Then, NaBH4 (8 mmol, 8
equiv.) was added portionwise, and the resulting mixture was
stirred for additional 8 h. Finally, the reaction mixture was
quenched with saturated ammonium chloride aqueous solution
(10 mL) and was then allowed to warm up to room
temperature. Then, it was extracted with DCM (3 × 10
mL). The resulting organic layers were washed with 1 M
hydrochloric acid (10 mL), then with sodium bicarbonate
saturated aqueous solution (10 mL), and finally with brine.
Washed organic portion was dried using Na2SO4 and
concentrated under vacuum. The resulting crude material
was purified by chromatography (silica gel, hexanes/ethyl
acetate (7:3 to 1:1)) to give the desired compound.
N1,N2-Dibutyl-1-phenylethane-1,2-diamine (2i). Yellow oil
(yield 76 g, 31%): 1H NMR (500 MHz, CDCl3) δ 7.35−7.23
(m, 5H), 3.80 (dd, J = 7.6, 6.3 Hz, 1H), 3.45 (br s, 2H), 2.91−
2.83 (m, 2H), 2.68 (qt, J = 11.6, 7.3 Hz, 2H), 2.51−2.39 (m,
2H), 1.55−1.40 (m, 4H), 1.37−1.24 (m, 4H), 0.89 (t, J = 7.4
Hz, 3H), 0.85 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (126 MHz,
CDCl3) δ 141.66, 128.63, 128.49, 127.22, 127.06, 62.00, 55.42,
48.93, 47.10, 32.03, 31.28, 20.38, 20.27, 13.87, 13.81 ppm;
HRMS (ESI) m/z calcd for C16H28N2 [M + H]
+: 249.2331,
found: 249.2329; IR (KBr) ν 3411, 3061, 3029, 2961, 2929,
2869, 1653, 1602, 1552, 1458, 1385, 762, 704 cm−1.
1-Phenyl-N1,N2-bis(3-phenylpropyl)ethane-1,2-diamine
(2j). Yellow oil (yield 144 g, 39%): 1H NMR (500 MHz,
CDCl3) δ 7.42−7.14 (m, 15H), 3.78 (dd, J = 8.6, 5.1 Hz, 1H),
2.90−2.79 (m, 2H), 2.77−2.61 (m, 8H), 2.61−2.51 (m, 2H),
1.93−1.77 (m, 4H) ppm; 13C NMR (126 MHz, CDCl3) δ
142.34, 142.21, 141.91, 128.58, 128.41, 128.32, 127.39, 127.22,
125.86, 125.74, 62.50, 56.11, 48.97, 47.03, 33.60, 33.50, 31.77,
31.28 ppm; HRMS (ESI) m/z calcd for C26H32N2 [M + H]
+:
373.2644, found: 373.2641; IR (KBr) ν 3164, 3068, 3034,
2994, 1583, 1494, 1478, 1460, 1449, 1401, 1326, 1314, 1288,
1232, 1192, 1181, 1166, 1152, 1087, 1077, 1059, 1025, 999,
982, 936, 909, 857, 809, 786, 762, 742, 716, 700, 687 cm−1.
2-Phenylpiperazine (3a). White crystals, mp 115−119 °C14
(yield 49 mg, 30%): 1H NMR (500 MHz, CDCl3) δ 7.40−7.32
(m, 5H), 3.79 (dd, J = 11.3, 2.8 Hz, 1H), 3.54 (br s, 1H),
3.33−3.21 (m, 2H), 3.00 (td, J = 12.5, 2.7 Hz, 1H), 2.89−2.76
(m, 1H), 2.67 (dt, J = 13.3, 11.5 Hz, 1H), 1.69 (br s, 2H)
ppm; 13C NMR (101 MHz, CDCl3) δ 140.0, 128.9, 128.2,
126.5, 60.7, 59.0, 52.3, 46.4 ppm; HRMS (ESI) m/z calcd for
C10H14N2 [M + H]
+: 163.1233, found: 163.1235; IR (KBr) ν
3166, 3092, 3071, 3059, 3035, 3002, 2232, 1918, 1904, 1800,
1602, 1584, 1493, 1480, 1451, 1422, 1386, 1324, 1311, 1287,
1267, 1227, 1189, 1161, 1147, 1115, 1102, 1088, 1070, 1056,
1041, 1025, 1013, 999, 928, 909, 855, 834, 808, 790, 749, 721,
704, 682 cm−1.
2-Methyl-3-(p-tolyl)piperazine (3b). White crystals, mp
161−163 °C15 (yield 60 mg, 34%): 1H NMR (400 MHz,
CDCl3) δ 7.16 (d, J = 8.1 Hz, 1H), 7.09 (d, J = 7.9 Hz, 1H),
3.66 (dd, J = 11.2, 2.7 Hz, 1H), 3.29 (br s, 1H), 3.22−3.12 (m,
2H), 2.91 (td, J = 12.4, 2.6 Hz, 1H), 2.74 (ddd, J = 25.2, 12.4,
3.3 Hz, 1H), 2.59 (dt, J = 13.2, 11.6 Hz, 1H), 2.27 (s, 3H),
1.47 (br s, 2H) ppm; 13C NMR (101 MHz, CDCl3) δ 138.3,
138.2, 129.5, 126.8, 60.5, 59.0, 52.3, 46.2, 21.1 ppm; HRMS
(ESI) m/z calcd for C11H17N2 [M + H]
+: 177.1390, found:
177.1392; IR (KBr) ν 3283, 3150, 3055, 3026, 2871, 2435,
2390, 2311, 2265, 2161, 2033, 1977, 1769, 1600, 1519, 1493,
1327, 1313, 1211, 1165, 1130, 1074, 1042, 1022, 1006, 953,
895, 859, 832, 801 cm−1.
2-Phenylquinoxaline (4). Orange crystals, mp 69−70 °C16
(yield 121 mg, 59%): 1H NMR (300 MHz, CDCl3) δ 9.22 (s,
1H), 8.13−7.97 (m, 4H), 7.71−7.57 (m, 2H), 7.49−7.38 (m,
3H) ppm; 13C NMR (75 MHz, CDCl3) δ 151.86, 143.39,
142.32, 141.60, 136.80, 130.31, 130.22, 129.66, 129.57, 129.18,
129.15, 127.58 ppm; HRMS (ESI) m/z calcd for C14H14N2 [M
+ H]+: 207.0922, found: 207.0922; IR (KBr) ν δ 3088, 3075,
3066, 2998, 1908, 1606, 1582, 1513, 1478, 1449, 1434, 1405,
1392, 1326, 1314, 1292, 1273, 1236, 1191, 1181, 1168, 1154,
1101, 1086, 1074, 1059, 1026, 1014, 999, 952, 937, 916, 865,
846, 802, 769, 757, 719, 688 cm−1.
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2b (Figure S5); 13C NMR spectrum of 2b (Figure S6);
1H NMR spectrum of 2c (Figure S7); 13C NMR
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